Regentis Biomaterials Ltd. (RGNT) income statement
RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.72−0.12 (-14.42%)
Close on Nov 20, 2026Market cap $3.72MP/E –Yield –
Regentis Biomaterials Ltd. financial ratios
See a number that looks wrong?